Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Br J Cancer ; 111(12): 2275-86, 2014 Dec 09.
Artigo em Inglês | MEDLINE | ID: mdl-25375271

RESUMO

BACKGROUND: Glioblastoma (GBM), being a highly vascularised and locally invasive tumour, is an attractive target for anti-angiogenic and anti-invasive therapies. The GBM/endothelial cell response to gossypol/temozolomide (TMZ) treatment was investigated with a particular aim to assess treatment effects on cancer hallmarks. METHODS: Cell viability, endothelial tube formation and GBM tumour cell invasion were variously assessed following combined treatment in vitro. The U87MG-luc2 subcutaneous xenograft model was used to investigate therapeutic response in vivo. Viable tumour response to treatment was interrogated using immunohistochemistry. Combined treatment protocols were also tested in primary GBM patient-derived cultures. RESULTS: An endothelial/GBM cell viability inhibitory effect, as well as an anti-angiogenic and anti-invasive response, to combined treatment have been demonstrated in vitro. A significantly greater anti-proliferative (P=0.020, P=0.030), anti-angiogenic (P=0.040, P<0.0001) and pro-apoptotic (P=0.0083, P=0.0149) response was observed when combined treatment was compared with single gossypol/TMZ treatment response, respectively. GBM cell line and patient-specific response to gossypol/TMZ treatment was observed. CONCLUSIONS: Our results indicate that response to a combined gossypol/TMZ treatment is related to inhibition of tumour-associated angiogenesis, invasion and proliferation and warrants further investigation as a novel targeted GBM treatment strategy.


Assuntos
Glioblastoma/tratamento farmacológico , Gossipol/farmacologia , Animais , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/patologia , Linhagem Celular Tumoral , Feminino , Glioblastoma/patologia , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Ensaios Antitumorais Modelo de Xenoenxerto
2.
Angiogenesis ; 14(4): 457-66, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21789714

RESUMO

Angiogenesis, the sprouting of new blood vessels from the pre-existing vasculature, is a well established target in anti-cancer therapy. It is thought that the Rho GTPase Rac1 is required during vascular endothelial growth factor (VEGF)-mediated angiogenesis. In the present study, we have used a clinically relevant RNA interference approach to silence Rac1 expression. Human umbilical vein endothelial cells were transiently transfected with non-specific control siRNA (siNS) or Rac1 siRNA (siRac1) using electroporation or Lipofectamine 2000. Functional assays with transfected endothelial cells were performed to determine the effect of Rac1 knockdown on angiogenesis in vitro. Silencing of Rac1 inhibited VEGF-mediated tube formation, cell migration, invasion and proliferation. In addition, treatment with Rac1 siRNA inhibited angiogenesis in an in vivo Matrigel plug assay. Intratumoral injections of siRac1 almost completely inhibited the growth of grafted Neuro2a tumors and reduced tumor angiogenesis. Together, these data indicate that Rac1 is an important regulator of VEGF-mediated angiogenesis. Knockdown of Rac1 may represent an attractive approach to inhibit tumor angiogenesis and growth.


Assuntos
Neoplasias/irrigação sanguínea , Neoplasias/tratamento farmacológico , Neovascularização Patológica/tratamento farmacológico , Interferência de RNA , RNA Interferente Pequeno/farmacologia , Proteínas rac1 de Ligação ao GTP/metabolismo , Análise de Variância , Sequência de Bases , Western Blotting , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Colágeno , Combinação de Medicamentos , Eletroporação , Humanos , Laminina , Dados de Sequência Molecular , Proteoglicanas , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Ensaio de Radioimunoprecipitação , Transfecção , Veias Umbilicais/citologia , Proteínas rac1 de Ligação ao GTP/genética
3.
Cryobiology ; 58(3): 268-74, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19444972

RESUMO

Antifreeze proteins (AFPs) were obtained from intercellular spaces of spruce needles Picea abies (L.) Karst. and Picea pungens Engelm. by vacuum infiltration with ascorbic acid, followed by centrifugation to recover the infiltrate. As shown by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS- PAGE), apoplastic proteins are accumulated in these spruce species as a group of 5-9 polypeptide bands. These proteins have a molecular mass of 7-80 kDa. The spruce AFPs have the ability to modify the growth of ice and thermal hysteresis, TH, caused by these AFPs was close to 2.0 degrees C at a concentration of 400 lg/ ml. The antifreeze activity of proteins from these winter-hardy coniferous species showed a positive correlation with the concentration of proteins after cold acclimation of needle tissues. Apoplastic proteins from winter spruce needles exhibited antifreeze activity, whereas no such activity was observed in extracts from summer needles. When we examined the possible role of spruce AFPs in cryoprotection, we found that lactate dehydrogenase, LDH, activity was higher after freezing in the presence of AFPs compared with bovine serum albumin. Amino-terminal sequence comparisons indicated that a 27-kDa protein from both P. abies and P. pungens was similar to some pathogenesis-related proteins namely chitinases, also from conifer species. These results show that spruces produce AFPs that are secreted into the apoplast of needles. The accumulation of AFPs in extracellular spaces caused by seasonal cold acclimation during winter indicates that these proteins may play a role in the acquisition of freezing tolerance of needle cells in coniferous species.


Assuntos
Proteínas Anticongelantes/química , Crioprotetores/química , Picea/metabolismo , Proteínas de Plantas/química , Sequência de Aminoácidos , Proteínas Anticongelantes/isolamento & purificação , Proteínas Anticongelantes/metabolismo , Crioprotetores/metabolismo , Congelamento , Dados de Sequência Molecular , Proteínas de Plantas/isolamento & purificação , Proteínas de Plantas/metabolismo , Especificidade da Espécie
7.
Oral Surg Oral Med Oral Pathol ; 40(3): 365-75, 1975 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1101128

RESUMO

Immunofluorescent tests have proved to be of diagnostic importance for pemphigus, bullous pemphigoid, cicatricial pemphigoid, systemic lupus erythematosus, and discoid lupus erythematosus. Immunofluorescence test procedures, necessary specimens, and test findings have been reviewed as aids to dentists in the utilization and interpretation of these tests for the study of oral lesions.


Assuntos
Imunofluorescência , Lúpus Eritematoso Discoide/diagnóstico , Lúpus Eritematoso Sistêmico/diagnóstico , Doenças da Boca/diagnóstico , Mucosa Bucal/patologia , Pênfigo/diagnóstico , Dermatopatias Vesiculobolhosas/diagnóstico , Pele/patologia , Anticorpos Antinucleares/análise , Biópsia , Humanos , Lúpus Eritematoso Discoide/imunologia , Lúpus Eritematoso Discoide/patologia , Lúpus Eritematoso Sistêmico/imunologia , Lúpus Eritematoso Sistêmico/patologia , Doenças da Boca/imunologia , Doenças da Boca/patologia , Pênfigo/imunologia , Pênfigo/patologia , Dermatopatias Vesiculobolhosas/imunologia , Dermatopatias Vesiculobolhosas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA